Provided by Tiger Trade Technology Pte. Ltd.

Aquestive Therapeutics Inc.

5.63
-0.1900-3.26%
Pre-market: 5.710.0800+1.42%08:45 EST
Volume:1.53M
Turnover:8.81M
Market Cap:686.88M
PE:-8.10
High:5.91
Open:5.82
Low:5.61
Close:5.82
52wk High:7.55
52wk Low:2.12
Shares:122.00M
Float Shares:115.00M
Volume Ratio:0.62
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6953
EPS(LYR):-0.5089
ROE:148.50%
ROA:-25.50%
PB:-167.16
PE(LYR):-11.06

Loading ...

Aquestive Therapeutics Inc. CEO Daniel Barber Reports Disposal of Common Shares

Reuters
·
Sep 24

Officer Peter E. Boyd Reports Disposal of Common Shares in Aquestive Therapeutics Inc

Reuters
·
Sep 09

Oppenheimer Adjusts Aquestive Therapeutics Price Target to $8 From $7, Maintains Outperform Rating

MT Newswires Live
·
Sep 08

Aquestive Therapeutics, Inc. : Oppenheimer Raises Target Price to $8 From $7

THOMSON REUTERS
·
Sep 08

Aquestive Therapeutics Shares Rise, FDA Forgos Meeting on Anaphylm

Dow Jones
·
Sep 05

BUZZ-U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum

Reuters
·
Sep 04

Aquestive Therapeutics Up Nearly 19%, On Pace For Largest Percent Increase Since March 2024 -- Data Talk

Dow Jones
·
Sep 04

BUZZ-Aquestive climbs after US FDA says no advisory panel needed for epinephrine film

Reuters
·
Sep 04

BRIEF-Aquestive Therapeutics Announces That FDA Will Not Require An Advisory Committee Meeting To Discuss New Drug Application For Anaphylm™

Reuters
·
Sep 04

Aquestive Therapeutics Announces That FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™

THOMSON REUTERS
·
Sep 04

Aquestive Therapeutics Inc - Pdufa Target Action Date for Anaphylm Is January 31, 2026

THOMSON REUTERS
·
Sep 04

Aquestive Therapeutics Inc. to Participate in Upcoming H.C. Wainwright Global Investor Conference

Reuters
·
Aug 26

BUZZ-Aquestive Therapeutics rises after $85 million stock sale

Reuters
·
Aug 15

Aquestive Therapeutics Prices $85 Million Common Stock Offering

MT Newswires Live
·
Aug 14

Aquestive Therapeutics Files Final Prospectus Supplement for $85 Million Common Stock Offering

Reuters
·
Aug 14

Aquestive Therapeutics Inc - Prices 21,250,000 Shares at $4.00 per Share

THOMSON REUTERS
·
Aug 14

Aquestive Therapeutics Inc - Proceeds to Advance Anaphylm Launch and Commercialization

THOMSON REUTERS
·
Aug 14

Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock

THOMSON REUTERS
·
Aug 14

Aquestive Therapeutics Secures $75 Million Funding to Propel Anaphylm Expansion Pending FDA Approval

Reuters
·
Aug 14

Aquestive Therapeutics Announces $75M Strategic Funding Agreement With Rtw to Support the Potential Launch of Anaphylm™ (Epinephrine) Sublingual Film

THOMSON REUTERS
·
Aug 14